Concepedia

Long Cui

LC

Statistics

Publications

18

Citations

1K

H-Index

16

Active since

1997

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Hubei University of Arts and Science

Xuzhou Central Hospital

Xiangyang Central Hospital

Boehringer Ingelheim (United States)

Long Cui is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, life sciences, and oncology.

ORCID

Publications per year

1997–2022

18

Publications

18

Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha

V Ramsfjell, Ole Johan Borge, Long Cui et al. · The Journal of Immunology · 1997 · 144 citations · Full text

, , +17

Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice

Michaela C. Stanton, Shu‐Cheng Chen, James V. Jackson et al. · Journal of Inflammation · 2011 · 135 citations · Full text

, , +13

Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice

Eva‐Pia Reich, Long Cui, Lily Yang et al. · European Journal of Immunology · 2005 · 87 citations

, , +17

A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection

Chung‐Her Jenh, Mary Ann Cox, Long Cui et al. · BMC Immunology · 2012 · 84 citations · Full text

, , +17

A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection

Chung‐Her Jenh, Mary Ann Cox, Long Cui et al. · BMC Immunology · 2012 · 83 citations · Full text

, , +17

1–5 of 18